LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 52

Search options

  1. Article ; Online: CXCR3-CXCL9: It's All in the Tumor.

    Humblin, Etienne / Kamphorst, Alice O

    Immunity

    2019  Volume 50, Issue 6, Page(s) 1347–1349

    Abstract: In this issue of Immunity, Chow et al. (2019) show that the CXCR3-CXCL9 axis is required for reinvigoration of intratumoral ... ...

    Abstract In this issue of Immunity, Chow et al. (2019) show that the CXCR3-CXCL9 axis is required for reinvigoration of intratumoral CD8
    MeSH term(s) Chemokine CXCL10 ; Chemokine CXCL9 ; Dendritic Cells ; Humans ; Neoplasms ; Programmed Cell Death 1 Receptor ; Receptors, CXCR3 ; T-Lymphocytes
    Chemical Substances CXCL9 protein, human ; CXCR3 protein, human ; Chemokine CXCL10 ; Chemokine CXCL9 ; Programmed Cell Death 1 Receptor ; Receptors, CXCR3
    Language English
    Publishing date 2019-07-24
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 1217235-2
    ISSN 1097-4180 ; 1074-7613
    ISSN (online) 1097-4180
    ISSN 1074-7613
    DOI 10.1016/j.immuni.2019.05.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Universal recording of immune cell interactions in vivo.

    Nakandakari-Higa, Sandra / Walker, Sarah / Canesso, Maria C C / van der Heide, Verena / Chudnovskiy, Aleksey / Kim, Dong-Yoon / Jacobsen, Johanne T / Parsa, Roham / Bilanovic, Jana / Parigi, S Martina / Fiedorczuk, Karol / Fuchs, Elaine / Bilate, Angelina M / Pasqual, Giulia / Mucida, Daniel / Kamphorst, Alice O / Pritykin, Yuri / Victora, Gabriel D

    Nature

    2024  Volume 627, Issue 8003, Page(s) 399–406

    Abstract: Immune cells rely on transient physical interactions with other immune and non-immune populations to regulate their ... ...

    Abstract Immune cells rely on transient physical interactions with other immune and non-immune populations to regulate their function
    MeSH term(s) CD8-Positive T-Lymphocytes/cytology ; CD8-Positive T-Lymphocytes/immunology ; Cell Communication/immunology ; Dendritic Cells/cytology ; Dendritic Cells/immunology ; Ligands ; T-Lymphocytes, Regulatory/cytology ; T-Lymphocytes, Regulatory/immunology ; T Follicular Helper Cells/cytology ; T Follicular Helper Cells/immunology ; B-Lymphocytes/cytology ; B-Lymphocytes/immunology ; Germinal Center/cytology ; Single-Cell Gene Expression Analysis ; Epithelial Cells/cytology ; Epithelial Cells/immunology ; Intestinal Mucosa/cytology ; Intestinal Mucosa/immunology ; Lymphocytic choriomeningitis virus/immunology ; Lymphocytic Choriomeningitis/immunology ; Lymphocytic Choriomeningitis/virology ; Organ Specificity
    Chemical Substances Ligands
    Language English
    Publishing date 2024-03-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/s41586-024-07134-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1

    Humblin, Etienne / Korpas, Isabel / Lu, Jiahua / Filipescu, Dan / van der Heide, Verena / Goldstein, Simon / Vaidya, Abishek / Soares-Schanoski, Alessandra / Casati, Beatrice / Selvan, Myvizhi E / Gümüş, Zeynep H / Wieland, Andreas / Corrado, Mauro / Cohen-Gould, Leona / Bernstein, Emily / Homann, Dirk / Chipuk, Jerry / Kamphorst, Alice O

    Science immunology

    2023  Volume 8, Issue 86, Page(s) eadg0878

    Abstract: During persistent antigen stimulation, such as in chronic infections and cancer, CD8 T cells differentiate into a hypofunctional programmed death protein 1-positive (PD- ... ...

    Abstract During persistent antigen stimulation, such as in chronic infections and cancer, CD8 T cells differentiate into a hypofunctional programmed death protein 1-positive (PD-1
    MeSH term(s) T Cell Transcription Factor 1/genetics ; CD28 Antigens ; Programmed Cell Death 1 Receptor ; CD8-Positive T-Lymphocytes ; Cell Differentiation ; Transcription Factors
    Chemical Substances T Cell Transcription Factor 1 ; CD28 Antigens ; Programmed Cell Death 1 Receptor ; Transcription Factors
    Language English
    Publishing date 2023-08-25
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2470-9468
    ISSN (online) 2470-9468
    DOI 10.1126/sciimmunol.adg0878
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Characteristics and anatomic location of PD-1

    Im, Se Jin / Obeng, Rebecca C / Nasti, Tahseen H / McManus, Daniel / Kamphorst, Alice O / Gunisetty, Sivaram / Prokhnevska, Nataliya / Carlisle, Jennifer W / Yu, Ke / Sica, Gabriel L / Cardozo, Lucas E / Gonçalves, André N A / Kissick, Haydn T / Nakaya, Helder I / Ramalingam, Suresh S / Ahmed, Rafi

    Proceedings of the National Academy of Sciences of the United States of America

    2023  Volume 120, Issue 41, Page(s) e2221985120

    Abstract: CD8 T cells play an essential role in antitumor immunity and chronic viral infections. Recent findings have delineated the differentiation pathway of CD8 T cells in accordance with the progenitor-progeny relationship of ... ...

    Abstract CD8 T cells play an essential role in antitumor immunity and chronic viral infections. Recent findings have delineated the differentiation pathway of CD8 T cells in accordance with the progenitor-progeny relationship of TCF1
    MeSH term(s) Humans ; Animals ; Mice ; Lymphocytic Choriomeningitis ; Programmed Cell Death 1 Receptor/genetics ; Programmed Cell Death 1 Receptor/metabolism ; CD8-Positive T-Lymphocytes ; Lymphocytic choriomeningitis virus ; Persistent Infection ; Lung Neoplasms/metabolism ; Mice, Inbred C57BL
    Chemical Substances Programmed Cell Death 1 Receptor
    Language English
    Publishing date 2023-10-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2221985120
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping.

    Filipescu, Dan / Carcamo, Saul / Agarwal, Aman / Tung, Navpreet / Humblin, Étienne / Goldberg, Matthew S / Vyas, Nikki S / Beaumont, Kristin G / Demircioglu, Deniz / Sridhar, Subhasree / Ghiraldini, Flavia G / Capparelli, Claudia / Aplin, Andrew E / Salmon, Hélène / Sebra, Robert / Kamphorst, Alice O / Merad, Miriam / Hasson, Dan / Bernstein, Emily

    Nature cell biology

    2023  Volume 25, Issue 9, Page(s) 1332–1345

    Abstract: MacroH2A has established tumour suppressive functions in melanoma and other cancers, but an unappreciated role in the tumour microenvironment. Using an autochthonous, immunocompetent mouse model of melanoma, we demonstrate that mice devoid of macroH2A ... ...

    Abstract MacroH2A has established tumour suppressive functions in melanoma and other cancers, but an unappreciated role in the tumour microenvironment. Using an autochthonous, immunocompetent mouse model of melanoma, we demonstrate that mice devoid of macroH2A variants exhibit increased tumour burden compared with wild-type counterparts. MacroH2A-deficient tumours accumulate immunosuppressive monocytes and are depleted of functional cytotoxic T cells, characteristics consistent with a compromised anti-tumour response. Single cell and spatial transcriptomics identify increased dedifferentiation along the neural crest lineage of the tumour compartment and increased frequency and activation of cancer-associated fibroblasts following macroH2A loss. Mechanistically, macroH2A-deficient cancer-associated fibroblasts display increased myeloid chemoattractant activity as a consequence of hyperinducible expression of inflammatory genes, which is enforced by increased chromatin looping of their promoters to enhancers that gain H3K27ac. In summary, we reveal a tumour suppressive role for macroH2A variants through the regulation of chromatin architecture in the tumour stroma with potential implications for human melanoma.
    MeSH term(s) Animals ; Mice ; Cancer-Associated Fibroblasts ; Chromatin/genetics ; Gene Expression ; Histones/genetics ; Melanoma/genetics ; Tumor Microenvironment/genetics
    Chemical Substances Chromatin ; Histones
    Language English
    Publishing date 2023-08-21
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1474722-4
    ISSN 1476-4679 ; 1465-7392
    ISSN (online) 1476-4679
    ISSN 1465-7392
    DOI 10.1038/s41556-023-01208-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Manipulating the PD-1 pathway to improve immunity.

    Kamphorst, Alice O / Ahmed, Rafi

    Current opinion in immunology

    2013  Volume 25, Issue 3, Page(s) 381–388

    Abstract: PD-1 is an inhibitory receptor induced in T cells by antigen stimulation and sustained PD-1 expression plays a key role in T cell dysfunction. Blocking PD-1 signaling rescues exhausted T cells and is an effective treatment for chronic infections and ... ...

    Abstract PD-1 is an inhibitory receptor induced in T cells by antigen stimulation and sustained PD-1 expression plays a key role in T cell dysfunction. Blocking PD-1 signaling rescues exhausted T cells and is an effective treatment for chronic infections and cancer. Nonetheless, combining PD-1 pathway blockade to therapeutic vaccination should further improve T cell rescue. PD-1 is induced shortly after T cell priming, but little is known about the role of PD-1 in the initiation of immune responses. In addition, the PD-1 pathway may also modulate humoral responses, since both B cells and Tfh cells express PD-1. Therefore, even though much progress has been achieved by manipulation of the PD-1 pathway to rescue exhausted T cells, this powerful immunotherapy could still be further exploited.
    MeSH term(s) Animals ; Gene Expression Regulation ; Humans ; Ligands ; Programmed Cell Death 1 Receptor/genetics ; Programmed Cell Death 1 Receptor/immunology ; Signal Transduction ; T-Lymphocytes/immunology ; Vaccination
    Chemical Substances Ligands ; Programmed Cell Death 1 Receptor
    Language English
    Publishing date 2013-04-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1035767-1
    ISSN 1879-0372 ; 0952-7915
    ISSN (online) 1879-0372
    ISSN 0952-7915
    DOI 10.1016/j.coi.2013.03.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: CD4 T-cell immunotherapy for chronic viral infections and cancer.

    Kamphorst, Alice O / Ahmed, Rafi

    Immunotherapy

    2013  Volume 5, Issue 9, Page(s) 975–987

    Abstract: During chronic infections and cancer, T cells progressively lose function and become exhausted. However, effective T-cell responses are necessary to ultimately control viral infections and tumors. Hence, strategies that either restore endogenous immune ... ...

    Abstract During chronic infections and cancer, T cells progressively lose function and become exhausted. However, effective T-cell responses are necessary to ultimately control viral infections and tumors. Hence, strategies that either restore endogenous immune responses or provide functional T cells by adoptive immunotherapy need to be explored. CD8 T cells play a prominent role in viral infections, as well as cancer, but CD4 T cells are necessary to support CD8 T-cell function. In addition, CD4 T cells exert direct effector functions, induce optimal B-cell responses and orchestrate innate immunity. Therefore, we propose that adoptive transfer strategies should exploit CD4 T cells alone or in combination with CD8 T cells, for the treatment of chronic infections and cancer. Furthermore, since adoptively transferred cells are subject to exhaustion, combining adoptive transfer therapy with immunotherapies that inhibit T-cell exhaustion should maximize the longevity and success rate of responses.
    MeSH term(s) Adoptive Transfer/methods ; Animals ; B-Lymphocytes/immunology ; B-Lymphocytes/pathology ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/transplantation ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; Chronic Disease ; Humans ; Immunity, Innate ; Neoplasms/immunology ; Neoplasms/pathology ; Neoplasms/therapy ; Virus Diseases/immunology ; Virus Diseases/pathology ; Virus Diseases/therapy
    Language English
    Publishing date 2013-09-02
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ISSN 1750-7448
    ISSN (online) 1750-7448
    DOI 10.2217/imt.13.91
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Dendritic Cells in Tolerance and Immunity against Pathogens.

    Boscardin, Silvia Beatriz / Rosa, Daniela Santoro / Kamphorst, Alice O / Trumpfheller, Christine

    Journal of immunology research

    2016  Volume 2016, Page(s) 6438036

    MeSH term(s) Animals ; Cardiovascular Diseases/genetics ; Cardiovascular Diseases/immunology ; Cardiovascular Diseases/pathology ; Dendritic Cells/immunology ; Dendritic Cells/pathology ; Humans ; Immune Tolerance ; Immunity ; Lupus Erythematosus, Systemic/genetics ; Lupus Erythematosus, Systemic/immunology ; Lupus Erythematosus, Systemic/pathology ; Mice
    Language English
    Publishing date 2016
    Publishing country Egypt
    Document type Editorial
    ZDB-ID 2817541-4
    ISSN 2314-7156 ; 2314-8861
    ISSN (online) 2314-7156
    ISSN 2314-8861
    DOI 10.1155/2016/6438036
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Immune checkpoint inhibitors in advanced non-small cell lung cancer.

    Assi, Hazem I / Kamphorst, Alice O / Moukalled, Nour M / Ramalingam, Suresh S

    Cancer

    2017  Volume 124, Issue 2, Page(s) 248–261

    Abstract: The emergence of immune checkpoint inhibitors for the treatment of cancer has led to major changes to the therapeutic landscape of lung cancer. Improvements in overall survival relative to standard chemotherapy have been observed in the first-line and ... ...

    Abstract The emergence of immune checkpoint inhibitors for the treatment of cancer has led to major changes to the therapeutic landscape of lung cancer. Improvements in overall survival relative to standard chemotherapy have been observed in the first-line and second-line therapy settings for patients with advanced non-small cell lung cancer (NSCLC) who are treated with immune checkpoint inhibitors. Consequently, every patient with advanced-stage NSCLC is now a candidate for immune checkpoint inhibitor therapy. However, it is clear that the benefit from therapy is not universal, and identification of biomarkers to select therapy has assumed importance. In addition to programmed cell death receptor ligand 1 expression, both tissue-based and blood-based markers are under evaluation to select patients. In an era of increasing costs of care and potential for toxicities related to immune checkpoint inhibition, proper patient selection is critical to the optimal use of this new class of agents. In addition, development of novel combination approaches has also emerged as an important way to improve the efficacy of immune checkpoint inhibition. Studies in earlier stages of NSCLC are already underway with the hope of improving the cure rate. In this article, the authors review the current landscape of immune checkpoint inhibitors in the treatment of advanced NSCLC. Cancer 2018;124:248-61. © 2017 American Cancer Society.
    MeSH term(s) B7-H1 Antigen/antagonists & inhibitors ; Biomarkers ; CTLA-4 Antigen/antagonists & inhibitors ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Humans ; Immunotherapy ; Lung Neoplasms/drug therapy ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Salvage Therapy
    Chemical Substances B7-H1 Antigen ; Biomarkers ; CTLA-4 Antigen ; Programmed Cell Death 1 Receptor
    Language English
    Publishing date 2017-12-06
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1429-1
    ISSN 1097-0142 ; 0008-543X ; 1934-662X
    ISSN (online) 1097-0142
    ISSN 0008-543X ; 1934-662X
    DOI 10.1002/cncr.31105
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Manipulating the PD-1 pathway to improve immunity

    Kamphorst, Alice O / Ahmed, Rafi

    Current Opinion in Immunology. 2013 June, v. 25, no. 3

    2013  

    Abstract: PD-1 is an inhibitory receptor induced in T cells by antigen stimulation and sustained PD-1 expression plays a key role in T cell dysfunction. Blocking PD-1 signaling rescues exhausted T cells and is an effective treatment for chronic infections and ... ...

    Abstract PD-1 is an inhibitory receptor induced in T cells by antigen stimulation and sustained PD-1 expression plays a key role in T cell dysfunction. Blocking PD-1 signaling rescues exhausted T cells and is an effective treatment for chronic infections and cancer. Nonetheless, combining PD-1 pathway blockade to therapeutic vaccination should further improve T cell rescue. PD-1 is induced shortly after T cell priming, but little is known about the role of PD-1 in the initiation of immune responses. In addition, the PD-1 pathway may also modulate humoral responses, since both B cells and Tfh cells express PD-1. Therefore, even though much progress has been achieved by manipulation of the PD-1 pathway to rescue exhausted T cells, this powerful immunotherapy could still be further exploited.
    Keywords T-lymphocytes ; antigens ; humoral immunity ; immune response ; vaccination
    Language English
    Dates of publication 2013-06
    Size p. 381-388.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 1035767-1
    ISSN 1879-0372 ; 0952-7915
    ISSN (online) 1879-0372
    ISSN 0952-7915
    DOI 10.1016/j.coi.2013.03.003
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top